Osaic Holdings’s Trillium Therapeutics Inc. TRIL Stock Holding History

Osaic Holdings’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-53,572	Closed	-$940K	–	7829
2021 Q3	$940K	Buy	53,572 +8,434	+19%	+$98.5K	﹤0.01%	2407
2021 Q2	$439K	Buy	45,138 +7,570	+20%	+$71.2K	﹤0.01%	3159
2021 Q1	$403K	Buy	37,568 +3,218	+9%	+$39.8K	﹤0.01%	3108
2020 Q4	$506K	Buy	34,350 +20,390	+146%	+$294K	﹤0.01%	2622
2020 Q3	$199K	Buy	13,960 +7,300	+110%	+$72.8K	﹤0.01%	3264
2020 Q2	$54K	Buy	6,660 +2,000	+43%	+$12.4K	﹤0.01%	4142
2020 Q1	$19K	Buy	+4,660	New	+$17.6K	﹤0.01%	4683

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Osaic Holdings's TRIL Position: Q4 2021 in Review

Osaic Holdings sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 53,572 shares — an estimated $940K sold.

Osaic Holdings first reported a position in TRIL in Q1 2020 and held it in 7 quarters. The position peaked at $940K in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Osaic Holdings reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Osaic Holdings sold 53,572 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $940K.
Osaic Holdings first reported a position in Trillium Therapeutics Inc. in Q1 2020 and held it in 7 quarters.
Osaic Holdings's Trillium Therapeutics Inc. position peaked at $940K in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Osaic Holdings's 13F filing for Q4 2021, filed 3 Feb 2022.